Abstracts

OPTIMIZING DOSING REGIMENS OF TRASTUZUMAB EMTANSINE AND TRASTUZUMAB DERUXTECAN: A MODEL-INFORMED COST-SAVING APPROACH

Thursday 7 May, 2026

Introductions: Approximately 15-20% of breast cancers overexpress human epidermal growth factor receptor 2 (HER2), a molecular subtype associated with poor…

Read more

Quantitative systems pharmacology model for follicle development and oocyte retrieval during ovarian stimulation

Thursday 7 May, 2026

Introduction: Based on 48 years of improving in-vitro fertilisation (IVF) treatment protocols, there is today a deep mechanistic understanding of…

Read more

ACTIVE LEARNING WITH BAYESIAN OPTIMIZATION FOR EFFICIENT VIRTUAL POPULATION GENERATION USING QUANTITATIVE SYSTEMS PHARMACOLOGY MODELS

Thursday 7 May, 2026

Objectives: Virtual population generation requires identifying feasible parameter combinations that produce physiologically realistic model outputs. Random sampling scales poorly with…

Read more

Translational modelling of pembrolizumab reveals a knowledge gap in immune checkpoint inhibitor dose development

Thursday 7 May, 2026

Background Optimal dosing of immune checkpoint inhibitors (ICI) like programmed death-1 (PD-1) inhibitors remains uncertain, as dose–response relationships are not…

Read more

DOES THEORETICAL TARGET ATTAINMENT REFLECT REAL-WORLD TARGET ACHIEVEMENT? AN EVALUATION IN INTENSIVE CARE UNIT PATIENTS RECEIVING PIPERACILLIN AS CONTINUOUS INFUSION

Thursday 7 May, 2026

Introduction: Model-informed precision dosing (MIPD) aims to individualise antimicrobial therapy using pharmacokinetic models. These models need to be evaluated prior…

Read more

Host Immunity as a Bidirectional Regulator of Phage Therapy: A Mechanism-Based PKPD Modeling Approach

Thursday 7 May, 2026

Objectives Bacteriophage therapy in immunocompetent hosts is governed not only by phage replication and bacterial dynamics, but also by host…

Read more

Simulation-based guideline implementation of weight-banded dosing strategies for childhood leprosy

Thursday 7 May, 2026

Introduction Leprosy remains an important cause of morbidity among children in vulnerable settings. Treatment consists of a 6- to 12-month…

Read more

Sensitivity analysis and calibration for a computationally expensive PBPK model: a case study for the PERSERISâ„¢ in-situ forming PLGA-based implant

Thursday 7 May, 2026

Introduction: Sensitivity Analysis (SA) describes a class of methods for studying the relationships between the inputs and outputs of a…

Read more

A Modular PBPK-QSP Platform for Renal–Cardiovascular Pharmacology: Simulating RAAS-Targeted Therapies and Drug-Induced Kidney Injury

Thursday 7 May, 2026

Objectives Mechanistic modeling offers a unique opportunity to integrate complex renal and cardiovascular physiology with pharmacological interventions. Dogs have historically…

Read more

Drug interaction between pyrazinamide and standard- and high-dose rifampicin

Thursday 7 May, 2026

Background and objective: Pyrazinamide is an essential component of the first-line combination treatment for drug-susceptible tuberculosis (TB), taken by approximately…

Read more